CONMED Quarterly Balance Sheet
NYSE: CNMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CONMED financial position
As of Jun 30, 2026, CONMED reported total assets of $2.30 billion, up 0.1% from a year earlier against total liabilities of $1.26 billion. Shareholders' equity stood at $1.04 billion, or 45.3% of assets. The company held $37.3 million in cash and equivalents against $834.2 million of debt, a net debt position of $796.9 million.
The current ratio (current assets divided by current liabilities) was 1.48, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.80.
Summary generated from market data by MetaCap's automated system. Methodology
CONMED balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 37.33M | 40.82M | 38.93M | 33.94M | 35.48M | 24.46M | 38.47M | 28.87M | 33.85M | 24.30M | 30.50M | 27.85M |
| Receivables | 239.77M | 247.83M | 224.94M | 234.15M | 221.14M | 237.73M | 231.23M | 239.22M | 241.46M | 242.28M | 230.20M | 229.26M |
| Inventory | 360.18M | 355.54M | 364.36M | 362.25M | 354.68M | 346.72M | 342.55M | 322.36M | 322.30M | 318.32M | 325.82M | 327.31M |
| Total Current Assets | 675.66M | 672.86M | 662.16M | 657.78M | 639.00M | 640.01M | 641.00M | 623.83M | 635.72M | 615.65M | 625.65M | 615.52M |
| Property, Plant & Equipment | 110.14M | 113.33M | 112.04M | 116.86M | 116.06M | 115.79M | 117.42M | 117.09M | 117.95M | 120.72M | 120.44M | 116.79M |
| Goodwill | 796.90M | 807.01M | 806.92M | 806.93M | 805.70M | 805.36M | 806.87M | 806.20M | 806.28M | 806.84M | 815.14M | 815.63M |
| Intangible Assets | 564.42M | 582.05M | 593.11M | 601.82M | 609.83M | 617.66M | 625.57M | 633.24M | 641.31M | 649.48M | 657.35M | 665.58M |
| Total Assets | 2.30B | 2.33B | 2.32B | 2.33B | 2.30B | 2.31B | 2.32B | 2.29B | 2.31B | 2.30B | 2.33B | 2.32B |
| Accounts Payable | 101.02M | 93.65M | 107.09M | 101.05M | 95.73M | 102.25M | 104.57M | 101.29M | 101.64M | 88.22M | 81.87M | 78.58M |
| Short-Term Debt | 177.20M | 712.00K | 746.00K | 714.00K | 714.00K | 715.00K | 717.00K | 716.00K | 692.00K | 708.00K | 70.63M | 69.63M |
| Total Current Liabilities | 455.40M | 315.04M | 314.70M | 294.84M | 283.15M | 278.13M | 282.31M | 266.41M | 291.40M | 310.73M | 376.32M | 353.17M |
| Long-Term Debt | 657.05M | 834.23M | 853.01M | 881.11M | 891.44M | 905.07M | 940.09M | 965.17M | 990.11M | 973.14M | 942.17M | 971.48M |
| Total Liabilities | 1.26B | 1.29B | 1.31B | 1.33B | 1.32B | 1.34B | 1.38B | 1.40B | 1.45B | 1.47B | 1.53B | 1.54B |
| Shareholders' Equity | 1.04B | 1.03B | 1.01B | 1.00B | 977.64M | 962.68M | 932.90M | 881.83M | 854.66M | 834.22M | 796.21M | 780.19M |
| Retained Earnings | 625.66M | 588.77M | 572.03M | 575.36M | 560.13M | 560.28M | 532.70M | 489.89M | 466.08M | 452.53M | 425.61M | 415.92M |
| Total Debt | 834.25M | 834.94M | 853.75M | 881.83M | 892.16M | 905.78M | 940.81M | 965.89M | 990.80M | 973.85M | 1.01B | 1.04B |
| Net Cash (Debt) | -796.92M | -794.13M | -814.82M | -847.89M | -856.67M | -881.32M | -902.34M | -937.02M | -956.95M | -949.55M | -982.29M | -1.01B |
This table shows 12 quarterly periods of CONMED's balance sheet, from Q2 2026 back to Q2 2023, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow CNMD's reporting calendar. What is a balance sheet?